First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using (89)Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer

In what we believe to be a first-in-human study, we evaluated the safety and dosimetry of (89)Zr-pertuzumab PET/CT for human epidermal growth factor receptor 2 (HER2)–targeted imaging in patients with HER2-positive breast cancer. Methods: Patients with HER2-positive breast cancer and evidence of dis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Ulaner, Gary A., Lyashchenko, Serge K., Riedl, Christopher, Ruan, Shutian, Zanzonico, Pat B., Lake, Diana, Jhaveri, Komal, Zeglis, Brian, Lewis, Jason S., O’Donoghue, Joseph A.
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2018
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6004559/
https://ncbi.nlm.nih.gov/pubmed/29146695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.202010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados